Evidence map›Paper›PMID 29451777›Full record

ArticleBioconjugate chemistry2018

Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong Survival.

Praful R Nair, Cory Alvey, Xiaoling Jin, Jerome Irianto, Irena Ivanovska, Dennis E Discher

Abstract read
In one paragraph

Article in Bioconjugate chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Retinoids as anti-cancer agents and their mechanisms of action.American journal of cancer research · 2022
    Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Praful R NairNanoBioPolymers Lab, and Physical Sciences Oncology Center @ Penn , University of Pennsylvania , Philadelphia , Pennsylvania 19104 , United States.
Cory AlveyNanoBioPolymers Lab, and Physical Sciences Oncology Center @ Penn , University of Pennsylvania , Philadelphia , Pennsylvania 19104 , United States.
Xiaoling JinNanoBioPolymers Lab, and Physical Sciences Oncology Center @ Penn , University of Pennsylvania , Philadelphia , Pennsylvania 19104 , United States.
Jerome IriantoNanoBioPolymers Lab, and Physical Sciences Oncology Center @ Penn , University of Pennsylvania , Philadelphia , Pennsylvania 19104 , United States.
Irena IvanovskaNanoBioPolymers Lab, and Physical Sciences Oncology Center @ Penn , University of Pennsylvania , Philadelphia , Pennsylvania 19104 , United States.
Dennis E DischerNanoBioPolymers Lab, and Physical Sciences Oncology Center @ Penn , University of Pennsylvania , Philadelphia , Pennsylvania 19104 , United States.ORCID 0000-0001-6163-2229
Physical Sciences (United States) · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Robert H. Vonderheide · 1985 to 2026
$222.3M
PSOC@Penn Education and OutreachU54CA193417 · NCI · UNIVERSITY OF PENNSYLVANIA · PI DISCHER, DENNIS E. · 2015 to 2020
$10.5M
Nanoscience of 'Self' - reductionist approaches to hCD47 inhibition of phagocytesR01HL124106 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI DISCHER, DENNIS E. · 2014 to 2022
$3.1M
NCI NIH HHS P30 CA016520NCI NIH HHS U54 CA193417NHLBI NIH HHS R01 HL124106
6 · The paper itself

Abstract

Drug resistance and relapse is common in cancer treatments with chemotherapeutics, and while drug combinations with naturally occurring, differentiation-inducing retinoic acid (RA) provide remission-free cures for one type of liquid tumor, solid tumors present major problems for delivery. Here, inspired by filoviruses that can be microns in length, flexible filomicelles that self-assemble from an amphiphilic block copolymer (PEG-PCL) are shown to effectively deliver RA and paclitaxel (TAX) to several solid tumor models, particularly in the liver. These hydrophobic compounds synergistically load into the cores of the elongated micelles, and the coloaded micelles prove most effective at causing cell death, ploidy, and durable regression of tumors compared to free drugs or to separately loaded drugs. RA-TAX filomicelles also reduce mortality of human lung or liver derived cancers engrafted at liver, intraperitoneal, and subcutaneous sites in immunodeficient mice. In vitro studies show that the dual drug micelles effectively suppress proliferation while upregulating a generic differentiation marker. The results highlight the potency of dual-loaded filomicelles in killing cancer cells or else driving their differentiation away from growth.

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorDrug CarriersHumansLiverLiver NeoplasmsMiceMice, Inbred NODMicellesMice, SCIDPaclitaxelPolyestersPolyethylene GlycolsTretinoinAntineoplastic AgentsDrug CarriersMicellesPaclitaxelpolycaprolactonePolyestersPolyethylene GlycolsTretinoin

Identifiers

PMID29451777
PMCPMC6128960
OpenAlexW2789182003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.